Insider · CIK 0002006414
Daan Van Well
Files at SOPH (SOPHiA GENETICS SA). First filing Mar 20, 2026, latest Oct 7, 2026.
In brief
Daan Van Well files SEC Form 4 as officer at SOPH (SOPHiA GENETICS SA). Since Mar 20, 2026, Daan Van Well has reported 0 open-market buys worth $0 and 8 open-market sells worth $166k, the latest filed on Oct 7, 2026.
A track record needs three past buys with six months of prices behind them; Daan Van Well has 0, so none is measured yet.
The newest scored trade: sold $50k of SOPH on Oct 5, 2026, filed Oct 7, 2026, scored 17 (weak), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 8 sells worth $166k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
SOPH: SOPHiA GENETICS SA
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 17Weak | SOPHiA GENETICS SA | $50k 6,168 shares | -2% | +111% from low-8% from high | |
| 16Weak | SOPHiA GENETICS SA | $47k 6,168 shares | -2% | - | |
| 10Weak | SOPHiA GENETICS SA | $3,149 684 shares | -0% | +64% from low-15% from high | |
| 10Weak | SOPHiA GENETICS SA | $3,554 684 shares | -0% | +87% from low-6% from high | |
| 10Weak | SOPHiA GENETICS SA | $11k 2,400 shares | -1% | +69% from low-15% from high | |
| 10Weak | SOPHiA GENETICS SA | $23k 4,849 shares | -1% | +83% from low-12% from high | |
| 10Weak | SOPHiA GENETICS SA | $25k 5,105 shares | -1% | +86% from low-10% from high | |
| 10Weak | SOPHiA GENETICS SA | $3,274 684 shares | -0% | +83% from low-12% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Oct 5, 2026 | SOPH SOPHIA GENETICS SA | 6,168 0.01% of outstanding | $50k | Oct 5, 2026 | $47k |
| Sep 11, 2026 | SOPH SOPHIA GENETICS SA | 6,168 0.01% of outstanding | $47k | Sep 11, 2026 | none |
| May 19, 2026 | SOPH SOPHIA GENETICS SA | 684 0.00% of outstanding | $3,208 | May 19, 2026 | $66k |
| Apr 20, 2026 | SOPH SOPHIA GENETICS SA | 684 0.00% of outstanding | $3,612 | Apr 20, 2026 | $66k |
| Apr 6, 2026 | SOPH SOPHIA GENETICS SA | 12,354 0.02% of outstanding | $62k | Apr 6, 2026 | $10k |
| Mar 19, 2026 | SOPH SOPHIA GENETICS SA | 684 0.00% of outstanding | $3,358 | Mar 19, 2026 | $26k |
| Feb 19, 2026 | SOPH SOPHIA GENETICS SA | 684 0.00% of outstanding | $3,304 | Feb 19, 2026 | $26k |
| Jan 20, 2026 | SOPH SOPHIA GENETICS SA | 684 0.00% of outstanding | $3,728 | Jan 20, 2026 | $25k |
| Jan 5, 2026 | SOPH SOPHIA GENETICS SA | 4,107 0.01% of outstanding | $19k | Jan 5, 2026 | $20k |
| Oct 3, 2025 | SOPH SOPHIA GENETICS SA | 6,160 0.01% of outstanding | $28k | Oct 3, 2025 | $16k |
| Jul 3, 2025 | SOPH SOPHIA GENETICS SA | 6,279 0.01% of outstanding | $19k | Jul 3, 2025 | $28k |
| Mar 24, 2025 | SOPH SOPHIA GENETICS SA | 10,781 0.02% of outstanding | $33k | Mar 24, 2025 | $17k |
| Dec 26, 2024 | SOPH SOPHIA GENETICS SA | 5,815 0.01% of outstanding | $19k | Dec 24, 2024 | $15k |
| Nov 19, 2024 | SOPH SOPHiA GENETICS SA | 890 0.00% of outstanding | $2,937 | Nov 19, 2024 | $19k |
| Oct 22, 2024 | SOPH SOPHiA GENETICS SA | 892 0.00% of outstanding | $2,944 | Oct 22, 2024 | $20k |
| Oct 4, 2024 | SOPH SOPHiA GENETICS SA | 2,946 0.00% of outstanding | $9,545 | Oct 4, 2024 | $24k |
| Sep 19, 2024 | SOPH SOPHiA GENETICS SA | 1,670 0.00% of outstanding | $7,064 | Sep 19, 2024 | $25k |
| Aug 19, 2024 | SOPH SOPHiA GENETICS SA | 861 0.00% of outstanding | $2,876 | Aug 19, 2024 | $25k |
| Jul 19, 2024 | SOPH SOPHiA GENETICS SA | 861 0.00% of outstanding | $3,969 | Jul 19, 2024 | $25k |
| Jul 5, 2024 | SOPH SOPHiA GENETICS SA | 2,900 0.00% of outstanding | $14k | Jul 5, 2024 | $69k |
| Jun 20, 2024 | SOPH SOPHiA GENETICS SA | 856 0.00% of outstanding | $4,271 | Jun 20, 2024 | $65k |
| May 20, 2024 | SOPH SOPHiA GENETICS SA | 856 0.00% of outstanding | $3,886 | May 20, 2024 | $63k |
| Apr 19, 2024 | SOPH SOPHiA GENETICS SA | 856 0.00% of outstanding | $4,109 | Apr 19, 2024 | $59k |
| Apr 10, 2024 | SOPH SOPHiA GENETICS SA | 631 0.00% of outstanding | $3,105 | Apr 10, 2024 | $56k |
| Apr 3, 2024 | SOPH SOPHiA GENETICS SA | 10,910 0.02% of outstanding | $54k | Apr 3, 2024 | $2,227 |
Transactions
Every row this insider has filed, 14 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 5, 2026 | SOPH SOPHiA GENETICS SA | SOpen-market sale Ordinary Shares10b5-1 | -6,168 | $8.12 | $50k | 332,716 | 8 d ago |
| Sep 11, 2026 | SOPH SOPHiA GENETICS SA | SOpen-market sale Ordinary Shares10b5-1 | -6,168 | $7.63 | $47k | 338,884 | 31 d ago |
| May 19, 2026 | SOPH SOPHiA GENETICS SA | SOpen-market sale Ordinary Shares10b5-1 | -684 | $4.60 | $3,149 | 345,052 | May 20, 2026 |
| Apr 20, 2026 | SOPH SOPHiA GENETICS SA | SOpen-market sale Ordinary Shares10b5-1 | -684 | $5.20 | $3,554 | 345,736 | Apr 21, 2026 |
| Apr 10, 2026 | SOPH SOPHiA GENETICS SA | SOpen-market sale Ordinary Shares10b5-1 | -2,400 | $4.67 | $11k | 346,420 | Apr 14, 2026 |
| Apr 8, 2026 | SOPH SOPHiA GENETICS SA | SOpen-market sale Ordinary Shares10b5-1 | -2,861 | $4.85 | $14k | 350,808 | Apr 10, 2026 |
| Apr 9, 2026 | SOPH SOPHiA GENETICS SA | SOpen-market sale Ordinary Shares10b5-1 | -1,988 | $4.74 | $9,424 | 348,820 | Apr 10, 2026 |
| Apr 6, 2026 | SOPH SOPHiA GENETICS SA | SOpen-market sale Ordinary Shares10b5-1 | -2,705 | $4.86 | $13k | 356,069 | Apr 8, 2026 |
| Apr 2, 2026 | SOPH SOPHiA GENETICS SA | AGrant or award Ordinary Shares | +97,536 | $0.00 | $0 | 358,774 | Apr 8, 2026 |
| Apr 7, 2026 | SOPH SOPHiA GENETICS SA | SOpen-market sale Ordinary Shares10b5-1 | -2,400 | $4.87 | $12k | 353,669 | Apr 8, 2026 |
| Apr 2, 2026 | SOPH SOPHiA GENETICS SA | AGrant or award Share Option (Right to Buy)derivative | +142,216 | $0.00 | $0 | 142,216 | Apr 8, 2026 |
| Apr 2, 2026 | SOPH SOPHiA GENETICS SA | AGrant or award Ordinary Shares | +97,536 | $0.00 | $0 | 97,536 | Apr 3, 2026 |
| Apr 2, 2026 | SOPH SOPHiA GENETICS SA | AGrant or award Share Option (Right to Buy)derivative | +142,216 | $0.00 | $0 | 142,216 | Apr 3, 2026 |
| Mar 19, 2026 | SOPH SOPHiA GENETICS SA | SOpen-market sale Ordinary Shares10b5-1 | -684 | $4.79 | $3,274 | 261,238 | Mar 20, 2026 |
Questions about Daan Van Well
Answered from the filings on this page, as of the latest one.
Is Daan Van Well buying or selling?
In the last 12 months Daan Van Well reported 0 open-market buys worth $0 and 8 open-market sells worth $166k on SEC Form 4; the latest was sold $50k of SOPH on Oct 5, 2026. Grants, option exercises and tax withholding are not counted.
How did Daan Van Well's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Daan Van Well has 0.
Where does Daan Van Well file Form 4?
Daan Van Well has filed Form 4 at SOPH (SOPHiA GENETICS SA) as Chief Legal Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.